The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease. Review uri icon

Overview

abstract

  • Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, involving approximately 25% of the general population and increasing in prevalence in patient populations afflicted with metabolic syndrome and type 2 diabetes. This article discusses the complex interplay between NAFLD and chronic kidney disease (CKD), as well as the underlying pathogenesis and mechanisms through which NAFLD and CKD are linked. Exploration of these sophisticated relationships and causative factors is essential to accurately assessing kidney function in patients with NAFLD, recommending pharmacologic treatment of disease, and identifying favorable avenues for future investigation.

publication date

  • April 1, 2022

Research

keywords

  • Diabetes Mellitus, Type 2
  • Metabolic Syndrome
  • Non-alcoholic Fatty Liver Disease
  • Renal Insufficiency, Chronic

Identity

Scopus Document Identifier

  • 85128256340

Digital Object Identifier (DOI)

  • 10.1016/j.cld.2022.01.008

PubMed ID

  • 35487606

Additional Document Info

volume

  • 26

issue

  • 2